# A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

> **NCT06363760** · — · ENROLLING_BY_INVITATION · sponsor: **Editas Medicine, Inc.** · enrollment: 54 (estimated)

## Conditions studied

- Sickle Cell Disease
- Transfusion-dependent Beta-Thalassemia
- Hemoglobinopathies

## Interventions

- **OTHER:** Safety and efficacy assessments

## Key facts

- **NCT ID:** NCT06363760
- **Lead sponsor:** Editas Medicine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-06-17
- **Primary completion:** 2040-08
- **Final completion:** 2040-08
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06363760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06363760, "A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06363760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*